Onkologie. 2026:20(4):202-206 | DOI: 10.36290/xon.2026.037

Axillary management in breast cancer: a review of current diagnostic and therapeutic approaches

Eva Strecková, Michaela Klimeš Lipánová, Tomáš Büchler
Onkologická klinika, 2. LF UK a Fakultní nemocnice Motol a Homolka, Praha

Axillary management in breast cancer patients has undergone a significant transformation over the past decade, moving towards a de-escalation of surgical and radiotherapeutic therapy while maintaining oncological safety. This review article summarizes current approaches to the diagnosis and treatment of the axilla. It discusses in detail the indications for various treatment modalities, including modern systemic therapy and current trends in the de-escalation of surgical treatment and radiotherapy. Attention is also paid to post-treatment complications, particularly the prevention and treatment of lymphedema and rehabilitation.

Keywords: breast cancer, axilla, de-escalation, neoadjuvant therapy, radiotherapy, lymphedema, rehabilitation.

Accepted: September 21, 2026; Published: October 9, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Strecková E, Klimeš Lipánová M, Büchler T. Axillary management in breast cancer: a review of current diagnostic and therapeutic approaches. Onkologie. 2026;20(4):202-206. doi: 10.36290/xon.2026.037.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 60 CZK (2.5 EUR)
    will be unlocked 9.10.2027

    References

    1. Berg JW. The significance of axillary node levels in the study of breast carcinoma. Cancer. 1955;8(4):776-778. Go to original source...
    2. Turner-Warwick RT. The lymphatics of the breast. Br J Surg. 1959;46:574-582. Go to original source...
    3. Park KU, Somerfield MR, Nirupama A, et al. Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update. J Clin Oncol. 2025;43(15):1720-1741. doi: 10.1200/JCO-25-00099. Go to original source... Go to PubMed...
    4. Giuliano AE, Ballman KV, McCall L, et al. Effect of Axillary Dissection vs Axillary Radiation on 10-Year Total Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918-926. Go to original source...
    5. Cools-Lartigue J, Sinclair A, Trabulsi N, et al. Preoperative axillary ultrasound and fine-needle aspiration biopsy in the diagnosis of axillary metastases in breast cancer. Ann Surg Oncol. 2013;20(3):819-827. Go to original source...
    6. Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (AMAROS). Lancet Oncol. 2014;15(12): 1303-1310. Go to original source...
    7. Caudle AS, Yang WT, Krishnamurthy S, et al. Improved Axillary Staging of Breast Cancer After Neoadjuvant Chemotherapy: A Prospective Feasibility Study of Targeted Axillary Dissection. J Clin Oncol. 2016;34(16):1847-1854.
    8. Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609-618. Go to original source...
    9. Boughey JC, Ballman KV, Le-Petross HT, et al. Identification of sentinel lymph nodes in patients with node-positive breast cancer treated with neoadjuvant chemotherapy (ACOSOG Z1071): a multi-institutional cohort study. JAMA. 2013;310(14):1455-1461. Go to original source...
    10. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252(3):426-433. Go to original source...
    11. Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(10):1385-1393. Go to original source...
    12. Modrá kniha České onkologické společnosti - 31. aktualizace. Kolektiv autorů. Brno: MOÚ; 2025.
    13. Nitz U, Gluz O, Kümmel S, et al. Endocrine Therapy Response and 21-Gene Expression Assay (ADAPT). J Clin Oncol. 2017;35(7):713-722.
    14. Schmid P, Cortes J, Pusztai L, et al. Pembrolizumab for Early Triple-Negative Breast Cancer. N Engl J Med. 2020;382(9):810-821. Go to original source...
    15. von Minckwitz G, Huang CS, Mano MS, et al. Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer. N Engl J Med. 2019;380(7):617-628. Go to original source...
    16. Bartels SAL, Donker M, Poncet C, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (AMAROS): 10-year results of a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2023;24(11):1225-1235.
    17. Mamounas EP, Bandos H, White JR, et al. Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy. N Engl J Med. 2025;392(21):2113-2124. doi: 10.1056/NEJMoa2408331. Go to original source...
    18. Jimenez RB, Abdou Y, Anderson P, et al. Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Gui­deline. J Clin Oncol. 2025;43(30):3292-3311. Go to original source...
    19. Gillespie TC, Sayegh HE, Brunelle CL, et al. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg. 2018;7(4):379-403. Go to original source...
    20. Lippi L, de Sire A, Losco L, et al. Axillary Web Syndrome in Breast Cancer Women: What Is the Optimal Rehabilitation Strategy after Surgery? A Systematic Review. J Clin Med. 2022;11(13):3839. Go to original source...
    21. Davies C, Levenhagen K, Ryans K, et al. Physical therapy for breast cancer-related lymphedema: An updated systematic review. Physical Therapy. 2024;104(2):pzad168.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.